Jefferies & Co Downgrades Bio-Reference Labs (BRLI) to Hold
BRLI Hot Sheet
Rating Summary:1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Jefferies & Co downgrades Bio-Reference Labs (Nasdaq: BRLI) from Buy to Hold.
To see more analyst ratings on BRLI Click Here.
Bio-Reference Laboratories, Inc. (Bio-Reference) is principally engaged in providing clinical laboratory testing services, primarily to customers in the greater New York metropolitan area, as well as to customers in a number of other states.
To see more analyst ratings on BRLI Click Here.
Bio-Reference Laboratories, Inc. (Bio-Reference) is principally engaged in providing clinical laboratory testing services, primarily to customers in the greater New York metropolitan area, as well as to customers in a number of other states.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Wedbush Downgrades Maxwell Technologies (MXWL) to Neutral; Elevated Competitive and Supply Chain Risks
Create E-mail Alert Related Categories
DowngradesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
